Clinical Trial

COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO

Study acronym: NB-UVB
Enrolling by Invitation Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated June 24, 2025 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Patient of stable and limited vitiligo less than 20% BSA will be recruited And evaluation of efficacy and safety of narrowband UVB with topical tacrolimus vs narrowband UVB and calcipotriol will be assessed
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-11; most recent amendment 2025-06-23.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-06-23
Trial Details
NCT Number NCT06880042
Lead Sponsor Dr ayesha wahid
Conditions Vitiligo - Macular Depigmentation, Tacrolimus
Enrollment 60 participants
Start Date 2025-05-01
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-08-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-24